We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EQNR:EURONEXT OSLOEquinor ASA analysis

Data as of Oct 15, 2026 - not real-time

Latest price
$45.29
Risk: medium
5/10Medium risk

Summary

Equinor ASA is priced at $45.29 and its moving averages line up in bullish order, the shorter sitting above the longer. The last 30 days have gained 2.4%. With RSI at 62.6 the momentum picture is approaching overbought, alongside a bullish MACD signal. Recent trading has carved out support near $40.96 and resistance around $45.64.
On valuation the read is fair — earnings multiple of 12.3 versus a 19.3 sector average, below the peer group. Consensus targets land 13.3% below where the shares trade now. Revenue is growing at 37.4% on a 8.0% profit margin. The 3.47% dividend yield looks covered by current payout levels.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 33.1%, a beta of -1.01 and a maximum drawdown of 26.8%, position sizing matters here. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 6/10.

Top market events

  • The shares in Equinor ASA OSE: EQNR; NYSE: EQNR will as from today be traded on the Oslo Stock Exchange exclusive the...
  • Please see below information about transactions made under the third tranche of the 2026 share buy-back programme for...
  • Please see below information about transactions made under the third tranche of the 2026 share buy-back programme for...

Market outlook

Short term

< 1 year

Positive

Model confidence7/107 out of 10

Key factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 36.20
  • MACD momentum is positive

Medium term

1–3 years

Positive

Model confidence6/106 out of 10

Key factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 12.3 versus sector average of 19.3
  • Trading above the 200-day average of 36.20

Long term

> 3 years

Positive

Model confidence6/106 out of 10

Key factors

  • P/E of 12.3 versus sector average of 19.3
  • Analyst targets imply -13.3% versus the current price
  • Revenue growth of +37.4%

Key metrics

Financial health

Revenue Growth37.40%
Profit Margin7.97%
P/E Ratio12.3
ROE21.27%
ROA14.52%
Debt/Equity75.16
P/B Ratio5.1
Op. Cash Flow$23.1B
Free Cash Flow$29.4B
Industry P/E19.3

Technical analysis

TrendBullish
RSI62.6
Support$40.96
Resistance$45.64
MA 20$42.90
MA 50$42.53
MA 200$36.20
MACDBullish
VolumeStable
Fear & Greed Index90.04

Valuation

Fair Value$398.02
Target Price$39.29
Upside/Downside-13.25%
GradeFair
TypeBlend
Dividend Yield3.47%

Risk assessment

Beta-1.01
Volatility33.09%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.